MNKD Q1 2020 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M-7.0% YoY

Gross Profit

$9M53.6% margin

Operating Income

-$7M-43.9% margin

Net Income

-$9M-57.4% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+1.5%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$80M

Total Liabilities

$278M

Stockholders' Equity

-$198M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$17M	-7.0%
Gross Profit	$9M	$12M	-26.8%
Operating Income	-$7M	-$14M	+47.3%
Net Income	-$9M	-$15M	+37.4%

Revenue Segments

Product

$8M100%